28076 Federal Register / Vol. 72, No. 96 / Friday, May 18, 2007 / Notices 

2006, and July 25, 2006, to the Drug 

Enforcement Administration (DEA) to 

be registered as a bulk manufacturer of 

the basic classes of controlled 

substances listed in schedule I and II: 

Drug Schedule 

Codeine-N-Oxide (9053) .............. I 

Morphine-N-Oxide (9307) ............. I 

Codeine (9050) ............................. II 

Dihydrocodeine (9120) ................. II 

Oxycodone (9143) ........................ II 

Dihydromorphine (9145) ............... II 

Hydrocodone (9193) ..................... II 

Thebaine (9333) ........................... II 

Morphine (9300) ........................... II 

Oxymorphone (9652) ................... II 

The company plans to bulk 

manufacture the above listed controlled 

substances for sale and distribution to 

manufacturers for product development 

and formulation. 

By letter dated January 4, 2007, 

Noramco has withdrawn their request 

for Amphetamine (1100) and 

Methylphenidate (1724). 

No comments or objections have been 

received. DEA has considered the 

factors in 21 U.S.C. 823(a) and 

determined that the registration of 

Noramco Inc. to manufacture the listed 

basic classes of controlled substances is 

consistent with the public interest at 

this time. DEA has investigated 

Noramco Inc. to ensure that the 

company’s registration is consistent 

with the public interest. The 

investigation has included inspection 

and testing of the company’s physical 

security systems, verification of the 

company’s compliance with State and 

local laws, and a review of the 

company’s background and history. 

Therefore, pursuant to 21 U.S.C. 823, 

and in accordance with 21 CFR 

1301.33(a), the above named company is 

granted registration as a bulk 

manufacturer of the basic classes of 

controlled substances listed. 

Dated: May 8, 2007. 

Joseph T. Rannazzisi, 

Deputy Assistant Administrator, Office of 

Diversion Control, Drug Enforcement 

Administration. 

[FR Doc. E7–9631 Filed 5–17–07; 8:45 am] 

BILLING CODE 4410–09–P 

DEPARTMENT OF JUSTICE 

Drug Enforcement Administration 

Manufacturer of Controlled 

Substances; Notice of Registration 

By Notice dated July 26, 2006, and 

published in the Federal Register on 

August 2, 2006, (71 FR 43814), Noramco 

Inc., 1440 Olympic Drive, Athens, 

Georgia 30601, made application by 

letter to the Drug Enforcement 

Administration (DEA) to be registered as 

a bulk manufacturer of Methylphenidate 

(1724), a basic class of controlled 

substance listed in schedule II. 

The company plans to bulk 

manufacture methylphenidate for a 

customer to use in the production of a 

controlled substance product. 

No comments or objections have been 

received. DEA has considered the 

factors in 21 U.S.C. 823(a) and 

determined that the registration of 

Noramco Inc. to manufacture the listed 

basic class of controlled substance is 

consistent with the public interest at 

this time. DEA has investigated 

Noramco Inc. to ensure that the 

company’s registration is consistent 

with the public interest. The 

investigation has included inspection 

and testing of the company’s physical 

security systems, verification of the 

company’s compliance with State and 

local laws, and a review of the 

company’s background and history. 

Therefore, pursuant to 21 U.S.C. 823, 

and in accordance with 21 CFR 1301.33, 

the above named company is granted 

registration as a bulk manufacturer of 

the basic classes of controlled 

substances listed. 

Dated: May 14, 2007. 

Joseph T. Rannazzisi, 

Deputy Assistant Administrator, Office of 

Diversion Control, Drug Enforcement 

Administration. 

[FR Doc. E7–9651 Filed 5–17–07; 8:45 am] 

BILLING CODE 4410–09–P 

DEPARTMENT OF JUSTICE 

Drug Enforcement Administration 

Manufacturer of Controlled 

Substances; Notice of Registration 

By Notice dated December 14, 2006, 

and published in the Federal Register 

on December 22, 2006, (71 FR 77066), 

Organichem Corporation, 33 Riverside 

Avenue, Rensselaer, New York 12144, 

made application by renewal to the 

Drug Enforcement Administration 

(DEA) to be registered as a bulk 

manufacturer of the basic classes of 

controlled substances listed in schedule 

I and II: 

Drug Schedule 

Marihuana (7360) ......................... I 

Tetrahydrocannabinols (7370) ..... I 

Amphetamine (1100) .................... II 

Methylphenidate (1724) ................ II 

Drug Schedule 

Pentobarbital (2270) ..................... II 

Hydrocodone (9193) ..................... II 

Meperidine(9230) ......................... II 

Dextropropoxyphene (9273) ......... II 

Fentanyl (9801) ............................ II 

The company plans to manufacture 

bulk controlled substances for use in 

product development and for 

distribution to its customers. 

In reference to drug code 7360 

(Marihuana), the company plans to bulk 

manufacture cannabidiol as a synthetic 

intermediate. This controlled substance 

will be further synthesized to bulk 

manufacture a synthetic THC (7370). No 

other activity for this drug code is 

authorized for this registration. 

No comments or objections have been 

received. DEA has considered the 

factors in 21 U.S.C. 823(a) and 

determined that the registration of 

Organichem Corporation to manufacture 

the listed basic classes of controlled 

substances is consistent with the public 

interest at this time. DEA has 

investigated Organichem Corporation to 

ensure that the company’s registration is 

consistent with the public interest. The 

investigation has included inspection 

and testing of the company’s physical 

security systems, verification of the 

company’s compliance with State and 

local laws, and a review of the 

company’s background and history. 

Therefore, pursuant to 21 U.S.C. 823, 

and in accordance with 21 CFR 1301.33, 

the above named company is granted 

registration as a bulk manufacturer of 

the basic classes of controlled 

substances listed. 

Dated: May 14, 2007. 

Joseph T. Rannazzisi, 

Deputy Assistant Administrator, Office of 

Diversion Control, Drug Enforcement 

Administration. 

[FR Doc. E7–9612 Filed 5–17–07; 8:45 am] 

BILLING CODE 4410–09–P 

DEPARTMENT OF JUSTICE 

Drug Enforcement Administration 

Manufacturer of Controlled 

Substances; Notice of Registration 

By Notice dated January 16, 2007, and 

published in the Federal Register on 

January 23, 2007, (72 FR 2907), Organix 

Inc., 240 Salem Street, Woburn, 

Massachusetts 01801, made application 

by letter to the Drug Enforcement 

Administration (DEA) to be registered as 

a bulk manufacturer of 

Tetrahydrocannabinols (7370), a basic 


pwalker on PROD1PC71 with NOTICES